Glucose metabolism in patients with schizophrenia treated with antipsychotic agents

被引：0
|
作者：
Fukui, Naoki
Suzuki, Yutaro
Sawamura, Kazushi
Sugai, Takuro
Watanabe, Junzo
Ono, Shin
Murata, Shigeo
Suzuki, Yuji
Someya, Toshiyuki
机构：
[1] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan
[2] Suehirobashi Hosp, Niigata, Japan
[3] Iizuka Hosp, Fukushima, Japan
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2007年 / 22卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
O32
引用
收藏
页码：A10 / A10
页数：1
相关论文
共 50 条
  • [41] Working memory deficits in patients with schizophrenia treated with conventional or atypical antipsychotic drugs
    Müller, U
    Werheid, K
    Hammerstein, E
    Mikolaschek, G
    Sachweh, S
    Becker, T
    PHARMACOPSYCHIATRY, 2002, 35 (05) : X - X
  • [42] Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs
    Kucharska-Pietura, Katarzyna
    Tylec, Aneta
    Czernikiewicz, Andrzej
    Mortimer, Ann
    MEDICAL SCIENCE MONITOR, 2012, 18 (01): : CR44 - CR49
  • [43] THE IMPACT OF ALTERNATIVE ANTIPSYCHOTIC MEDICATIONS ON THE RISK OF ADVERSE EVENTS IN PATIENTS TREATED FOR SCHIZOPHRENIA
    Jiang, Y.
    Park, S.
    McCombs, J.
    VALUE IN HEALTH, 2015, 18 (03) : A115 - A115
  • [44] Cognitive function and depression in symptom resolution in schizophrenia patients treated with an atypical antipsychotic
    Stip, E
    Mancini-Marïe, A
    BRAIN AND COGNITION, 2004, 55 (03) : 463 - 465
  • [45] Metabolic disorders in patients with schizophrenia treated by antipsychotic drugs in Europe: the METEOR study
    Mauri, M.
    Falissard, B.
    De Hert, M.
    Shaw, K.
    Wetterling, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S444 - S444
  • [46] Antipsychotic polypharmacy in patients with schizophrenia
    Kim, Chan-Hyung
    ASIA-PACIFIC PSYCHIATRY, 2012, 4 : 19 - 19
  • [47] Prospective comparison of course of disability in antipsychotic-treated and untreated schizophrenia patients
    Thirthalli, J.
    Venkatesh, B. K.
    Kishorekumar, K. V.
    Arunachala, U.
    Venkatasubramanian, G.
    Subbakrishna, D. K.
    Gangadhar, B. N.
    ACTA PSYCHIATRICA SCANDINAVICA, 2009, 119 (03) : 209 - 217
  • [48] Antipsychotic polypharmacy and quality of life in patients with schizophrenia treated in primary care in China
    Hou, Cai-Lan
    Ma, Xin-Rong
    Zang, Yu
    Jia, Fu-Jun
    Lin, Yong-Qiang
    Chiu, Helen F. K.
    Ungvari, Gabor S.
    Ng, Chee H.
    Zhong, Bao-Liang
    Cao, Xiao-Lan
    Li, Yan
    Cai, Mei-Ying
    Xiang, Yu-Tao
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (01) : 36 - 42
  • [49] Relationship between costs and symptoms in schizophrenia patients treated with antipsychotic medication: A review
    Sevy, S
    Visweswaraiah, H
    Mentschel, C
    Leucht, S
    Schooler, NR
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (06) : 756 - 765
  • [50] Metabolic syndrome in schizophrenia: Differences between antipsychotic-naive and treated patients
    Chadda, Rakesh K.
    Ramshankar, Prashanth
    Deb, Koushik S.
    Sood, Mamta
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (03) : 176 - 186
12345